The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10 to 12 months for a review to just ...

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they could imperil the drug approval process that has served as the global ...

The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers working on products that could cure chronic disease, prepare for a pandemic ...

The FDA is looking into how AI could help with final drug approvals and improve internal tasks like checking whether an application is complete.

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Underinvestment in technology to adequately document data may contribute to gaps in the Food and Drug Administration’s drug review process. The FDA has consistently treated IT as a deferrable spending ...

The US Food and Drug Administration (FDA) is launching a “stronger, more systematic” review process for chemicals in food. The US government agency said in a statement, citing US Department of Health ...